β-Klotho: A Central Regulator of Metabolic Homeostasis and Novel Therapeutic Target

Published by ANT BIO PTE. LTD.

Concept

β-Klotho (KLB) is a single‑pass transmembrane protein and an essential coreceptor for endocrine fibroblast growth factors FGF19 and FGF21. It is a cornerstone of systemic metabolic regulation, governing glucose and lipid metabolism, insulin sensitivity, bile acid homeostasis, and energy balance. Unlike classical growth factor receptors, β-Klotho lacks kinase activity but enables high‑affinity binding of FGF19/21 to FGFR1c and FGFR4, thereby triggering downstream metabolic signaling. Its expression is highly enriched in metabolically active tissues including liver, adipose, pancreas, and intestine, making it a master regulator of whole‑body metabolic homeostasis.

[Image Location: β‑Klotho Signaling Pathway and Disease Association Network Diagram]

Research Frontier

β-Klotho has emerged as a high‑priority research target at the forefront of metabolism, aging, and chronic disease. Recent advances highlight its roles beyond classic FGF signaling, including epigenetic regulation, noncanonical protein interactions, and soluble fragment paracrine activity. Dysregulation is strongly linked to type 2 diabetes, NAFLD/NASH, obesity, and biliary diseases. Current cutting‑edge directions include substrate‑specific modulation, tissue‑restricted activation, soluble β‑Klotho as a biomarker, and combinatorial therapy with FGF21 mimetics. This rapidly evolving field positions β‑Klotho as a highly translational target for next‑generation metabolic disorder therapies.

Research Significance

Metabolic diseases represent a global health crisis, and β‑Klotho functions as a molecular hub integrating nutritional, hormonal, and inflammatory signals. Loss of β‑Klotho directly drives insulin resistance, hepatic steatosis, dyslipidemia, and disrupted bile acid metabolism. Conversely, enhancing β‑Klotho expression or activity alleviates multiple features of metabolic syndrome. High‑quality research tools are essential to dissect its regulatory mechanisms, validate disease associations, and screen therapeutic modulators. As such, β‑Klotho is indispensable for advancing precision medicine in diabetes, fatty liver disease, and obesity.

Related Mechanisms and Research Applications

Core Molecular Mechanisms

1. FGF Signaling Coreceptor

Forms complexes with FGFR1c and FGFR4 to enable FGF21‑mediated glucose/lipid control and FGF19‑mediated bile acid feedback inhibition.

2. Glucose Homeostasis

Enhances insulin sensitivity; suppresses hepatic gluconeogenesis; promotes GLUT1‑mediated glucose uptake in adipose tissue.

3. Lipid Metabolism

Inhibits hepatic lipogenesis; stimulates adipose lipolysis and browning; reduces hepatic lipid accumulation.

4. Bile Acid Homeostasis

Mediates gut‑liver FXR‑FGF19‑KLB feedback to suppress CYP7A1 and maintain bile acid balance.

5. Energy Balance

Regulates hypothalamic feeding behavior and peripheral energy expenditure.

Key Research Methods

• Immunodetection: IHC, WB, IF for localization and expression quantification
• Quantitative analysis: ELISA for serum and tissue β‑Klotho levels
• Signaling studies: FGFR phosphorylation, downstream metabolic gene expression
• Protein interaction: Co‑IP, pull‑down, cellular colocalization
• Disease models: dietary‑induced obesity, NAFLD, diabetic animal models

ANTBIO Product Empowerment

ANT BIO PTE. LTD. delivers a complete suite of reagents to accelerate β‑Klotho and metabolic research:

• β‑Klotho Specific Antibodies (Starter brand)

Validated for high specificity in IHC, WB, and IF; reliable detection in human, mouse, and rat tissues.

• β‑Klotho ELISA Kits (Absin brand)

Sensitive and precise quantification in serum, plasma, cell lysates, and tissue homogenates.

• Recombinant β‑Klotho Protein (UA brand)

Bioactive full‑length and extracellular domain proteins for in vitro binding and functional assays.

• Metabolic Research Reagents (Absin brand)

Optimized buffers, lysis solutions, and detection reagents for consistent experimental results.

These tools enable robust characterization of β‑Klotho expression, regulation, and function across basic and translational research.

Brand Mission

ANT BIO PTE. LTD. is dedicated to advancing breakthroughs in metabolic disease research by providing high‑quality, reliable reagents for molecular metabolism, endocrinology, and liver disease studies. Our integrated portfolio — spanning antibodies, recombinant proteins, ELISA kits, and universal laboratory reagents — supports reproducible, high‑impact studies worldwide. We strive to be the trusted partner of researchers as they uncover novel therapeutic targets and develop innovative treatments for metabolic disorders.

Related Product List

1. β-Klotho Monoclonal / Polyclonal Antibody

Catalog No.: S0Bxxxx

Applications: WB, IHC, IF

Reactivity: Human, Mouse, Rat

Features: High specificity, low background, excellent lot consistency

2. Human/Mouse/Rat β-Klotho ELISA Kit

Catalog No.: abs551xxx

Sample Type: Serum, plasma, tissue homogenate, cell lysate

Method: Sandwich ELISA, high sensitivity

3. Recombinant Human β-Klotho Protein

Catalog No.: UAxxxx

Purity: ≥95%

Application: Functional assay, protein interaction, inhibitor screening

4. General Metabolic Research Reagents

Brand: Absin

Includes: lysis buffer, blocking buffer, diluents, and secondary antibodies

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.